Streptococcus antigens
AssigneeID Biomedical Corporation
InventorsJosee Hamel, Nathalie Charland, Bernard R. Brodeur, Denis Martin, Normand Blais, Catherine Ouellet, Steve Labbe
Life of this patent
Estimating the term…
Abstract
The present invention relates to polypeptides of Streptococcus pneumoniae which may be used for prophylaxis, diagnostic and/or therapy purposes.
Claims31
An isolated polynucleotide comprising a polynucleotide chosen from;
- (a) a polynucleotide encoding a polypeptide having at least 70% identity to a second polypeptide chosen from:
- SEQ ID NO:
- 1, 2, 3, 90 to 115, 141 to 148 or fragments, analogs or derivatives thereof;
- (b) a polynucleotide encoding a polypeptide having at least 95% identity to a second polypeptide chosen from:
- SEQ ID NO:
- 1, 2, 3, 90 to 115, 141 to 148 or fragments, analogs or derivatives thereof;
- (c) a polynucleotide encoding a polypeptide having an amino sequence chosen from SEQ ID NO:
- 1, 2, 3, 90 to 115, 141 to 148 or fragments, analogs or derivatives thereof;
- (d) a polynucleotide encoding a polypeptide capable of raising antibodies having binding specificity for a polypeptide having a sequence chosen from:
- SEQ ID NO:
- 1, 2, 3, 90 to 115, 141 to 148 or fragments, analogs or derivatives thereof;
- (e) a polynucleotide encoding an epitope bearing portion of a polypeptide chosen from SEQ ID NO:
- 1, 2, 3, 90 to 115, 141 to 148 or fragments, analogs or derivatives thereof;
- (f) a polynucleotide comprising a sequence chosen from SEQ ID NOS:
- 4, 5 or 6 or fragments or analogs thereof;
- and
- (g) a polynycleotide complementary to a polynucleotide in (a), (b), (c), (d), (e) or (f).
An isolated polynucleotide comprising a polynucleotide chosen from;
- (a) a polynucleotide encoding a polypeptide having at least 70% identity to a second polypeptide chosen from:
- SEQ ID 1, 2, 3, 90 to 115 or 141 to 148;
- (b) a polynucleotide encoding a polypeptide having at least 95% identity to a second polypeptide chosen from:
- SEQ ID 1, 2, 3, 90 to 115 or 141 to 148;
- (c) a polynucleotide encoding a polypeptide having an amino sequence chosen from SEQ ID 1, 2, 3, 90 to 115 or 141 to 148;
- (d) a polynucleotide encoding a polypeptide capable of raising antibodies having binding specificity for a polypeptide having a sequence chosen from:
- SEQ ID 1, 2, 3, 90 to 115 or 141 to 148;
- (e) a polynucleotide encoding an epitope bearing portion of a polypeptide chosen from SEQ ID 1, 2, 3, 90 to 115 or 141 to 148;
- (f) a polynucleotide comprising a sequence chosen from SEQ ID NOS:
- 4, 5 or 6;
- and
- (g) a polynycleotide complementary to a polynucleotide in (a), (b), (c), (d), (e) or (f).
An isolated polynucleotide having a sequence comprising a sequence chosen from SEQ ID NOs:
- 4, 5, 6 or fragments or analogs thereof.
An isolated polynucleotide having a sequence comprising a sequence chosen from SEQ ID NOs:
- 4, 5 or 6.
An isolated polypeptide comprising a polypeptide chosen from:
- (a) a polypeptide having at least 70% identity to a second polypeptide having an amino acid sequence chosen from:
- SEQ ID NO:
- 1, 2, 3, 90 to 115, 141 to 148 or fragments, analogs or derivatives thereof;
- (b) a polypeptide having at least 95% identity to a second polypeptide having an amino acid sequence chosen from:
- SEQ ID NO:
- 1, 2, 3, 90 to 115, 141 to 148 or fragments, analogs or derivatives thereof;
- (c) a polypeptide having an amino acid sequence chosen from SEQ ID NO:
- 1, 2, 3, 90 to 115, 141 to 148 or fragments, analogs or derivatives thereof;
- (d) a polypeptide capable of raising antibodies having binding specificity for a second polypeptide having a sequence chosen from SEQ ID NO:
- 1, 2, 3, 90 to 115, 141 to 148 or fragments, analogs or derivatives thereof;
- (e) an epitope bearing portion of a polypeptide having an amino acid sequence chosen from:
- SEQ ID NO:
- 1, 2, 3, 90 to 115, 141 to 148 or fragments, analogs or derivatives thereof;
- (f) the polypeptide of (a), (b), (c), (d) or (e), wherein the N-terminal Met residue is deleted;
- or
- (g) the polypeptide of (a), (b), (c), (d), (e), or (f) wherein the secretory amino acid sequence is deleted.
an isolated polypeptide comprising a member chosen from:
- (a) a polypeptide having at least 70% identity to a second polypeptide having an amino acid sequence chosen from:
- SEQ ID NO:
- 1, 2, 3, 90 to 115 or 141 to 148;
- (b) a polypeptide having at least 95% identity to a second polypeptide having an amino acid sequence chosen from:
- SEQ ID NO:
- 1, 2, 3, 90 to 115 or 141 to 148;
- (c) a polypeptide having an amino acid sequence chosen from SEQ ID NO:
- 1, 2, 3, 90 to 115 or 141 to 148;
- (d) a polypeptide capable of raising antibodies having binding specificity for a second polypeptide having a sequence chosen from SEQ ID NO:
- 1, 2, 3, 90 to 115 or 141 to 148;
- (e) an epitope bearing portion of a polypeptide having an amino acid sequence chosen from:
- SEQ ID NO:
- 1, 2, 3, 90 to 115 or 141 to 148;
- (f) the polypeptide of (a), (b), (c), (d) or (e) wherein the N-terminal Met residue is deleted;
- or
- (g) the polypeptide of (a), (b), (c), (d), (e) or (f) wherein the secretory amino acid sequence is deleted.
A chimeric polypeptide comprising two or more polypeptides chosen from SEQ ID NO:
- 1, 2, 3, 90 to 115 or 141 to 148 or fragments, analogs or derivatives thereof;
- provided that the polypeptides are linked as to form a chimeric polypeptide.
A chimeric polypeptide comprising two or more polypeptides chosen from SEQ ID NO:
- 1, 2, 3, 90 to 115 or 141 to 148;
- provided that the polypeptides are linked as to form a chimeric polypeptide.
Dependencies are inferred from the claim text.